Riskpilot← Back to searchSign inGet full accessBIOGARDIA AB
ABActiveOrg 5568815459Kullevägen 10 AWholesale of other machinery and equipment · NACE 4664Est. 20120 employees
Revenue 2024
SEK 0
EBITDA margin
—
-50% vs 2023
Equity ratio
-25.0%
Financial strength
Net profit 2024
SEK -8K
-33% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | -50% |
| Net profit | SEK -8K | -33% |
| Total assets | SEK 16K | +60% |
| Equity | SEK -4K | -180% |
| Employees | 0 | — |
Legal name
BIOGARDIA AB
Org number
5568815459
Legal form
Aktiebolag
NACE code
4664 · Wholesale of other machinery and equipment
Founded
20 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Försäljning, distribution och service av laboratorieteknologi i Skandinavien, Finland och Baltikum, samt utveckling och produktion av analysinstrument.
Address
Kullevägen 10 A
Email
pvikegard@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | — | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | 0 | −6 | −6 | −9 |
| Depreciation & amort. | −0 | — | −0 | −0 | −0 |
| EBIT | −4 | 0 | −6 | −6 | −9 |
| Net financials | — | — | — | — | — |
| Profit before tax | −4 | 0 | −6 | −6 | −8 |
| Tax | −0 | — | −0 | −0 | −0 |
| Net profit | −4 | — | −6 | −6 | −8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 20 | — | 17 | 10 | 16 |
| Equity | 19 | — | 17 | 5 | −4 |
| Long-term debt | 0 | — | 0 | 0 | 15 |
| Short-term debt | 1 | — | 0 | 5 | 5 |
| Total debt | 1 | — | — | 5 | 20 |
EBITDA margin
-900000.0%
This company
15.8%
Market median
-5696303% vs market
20202024
Equity ratio
-25.0%
This company
38.2%
Market median
-165% vs market
20202024
Return on equity
-800000.0%
This company
18.4%
Market median
-4347926% vs market
20202024
Net profit margin
-800000.0%
This company
8.1%
Market median
-9876643% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
5.00×
This company
0.62×
Market median
-706% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
BP Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOGARDIA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Natalia Markova | Deputy Chief Executive Officer | 0 companies |
| Bengt Peter Vikegard | Chief Executive Officer | 0 companies |